Jessica Allegretti, MD, MPH

Jessica Allegretti, MD, MPH, graduated from Cornell University in Ithaca New York, and The Miller School of Medicine at the University of Miami in Miami, Florida. She was trained in internal medicine at Massachusetts’s General Hospital and completed her gastroenterology fellowship training at Brigham and Women’s Hospital. She later went on to receive a Master of Public Health degree from the Harvard School of Public Health.

Currently she is an attending gastroenterologist at the Brigham and Women’s Hospital Crohn’s and Colitis Center, where she also serves as the center’s Director of Clinical Trials. In addition to her clinical responsibilities, Dr. Allegretti is the director of the fecal microbiota transplant program at Brigham and Women’s Hospital. She is currently leading several clinical trials investigating the use of fecal transplantation in several chronic diseases such as Inflammatory Bowel Disease, Primary Sclerosing Cholangitis and obesity. Additionally, Dr. Allegretti’s lab focuses on investigating the mechanisms of recurrent clostridium difficile infections.


Posts by Jessica Allegretti, MD, MPH

New donor screening protocols for clinical trials involving fecal microbiota transplantation

The FDA has issued a safety alert about the risk of transmitting drug-resistant bacteria during a stool transplantation procedure, after the death of one person participating in a research protocol.

Stool transplants are now standard of care for recurrent C. difficile infections

Stool transplantation has become a standard treatment for people who have had multiple recurrent episodes of a bacterial infection; although the procedure has not been approved by the FDA, the success rate is high and the procedure is very safe.